Literature DB >> 29581292

Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.

Dean P Staus1,2, Laura M Wingler1,2, Minjung Choi3, Biswaranjan Pani1, Aashish Manglik4,5, Andrew C Kruse6, Robert J Lefkowitz7,2,3.   

Abstract

The ability of G protein-coupled receptors (GPCRs) to initiate complex cascades of cellular signaling is governed by the sequential coupling of three main transducer proteins, G protein, GPCR kinase (GRK), and β-arrestin. Mounting evidence indicates these transducers all have distinct conformational preferences and binding modes. However, interrogating each transducer's mechanism of interaction with GPCRs has been complicated by the interplay of transducer-mediated signaling events. For example, GRK-mediated receptor phosphorylation recruits and induces conformational changes in β-arrestin, which facilitates coupling to the GPCR transmembrane core. Here we compare the allosteric interactions of G proteins and β-arrestins with GPCRs' transmembrane cores by using the enzyme sortase to ligate a synthetic phosphorylated peptide onto the carboxyl terminus of three different receptors. Phosphopeptide ligation onto the β2-adrenergic receptor (β2AR) allows stabilization of a high-affinity receptor active state by β-arrestin1, permitting us to define elements in the β2AR and β-arrestin1 that contribute to the receptor transmembrane core interaction. Interestingly, ligation of the identical phosphopeptide onto the β2AR, the muscarinic acetylcholine receptor 2 and the μ-opioid receptor reveals that the ability of β-arrestin1 to enhance agonist binding relative to G protein differs substantially among receptors. Furthermore, strong allosteric coupling of β-arrestin1 correlates with its ability to attenuate, or "desensitize," G protein activation in vitro. Sortase ligation thus provides a versatile method to introduce complex, defined phosphorylation patterns into GPCRs, and analogous strategies could be applied to other classes of posttranslationally modified proteins. These homogeneously phosphorylated GPCRs provide an innovative means to systematically study receptor-transducer interactions.

Entities:  

Keywords:  G protein-coupled receptor; allostery; phosphorylation; sortase; β-arrestin

Mesh:

Substances:

Year:  2018        PMID: 29581292      PMCID: PMC5899476          DOI: 10.1073/pnas.1722336115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

2.  A brief history of G-protein coupled receptors (Nobel Lecture).

Authors:  Robert J Lefkowitz
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

Review 3.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

4.  Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.

Authors:  Jihee Kim; Seungkirl Ahn; Xiu-Rong Ren; Erin J Whalen; Eric Reiter; Huijun Wei; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

5.  Expressed protein ligation: a general method for protein engineering.

Authors:  T W Muir; D Sondhi; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 6.  Structural Basis for G Protein-Coupled Receptor Activation.

Authors:  Aashish Manglik; Andrew C Kruse
Journal:  Biochemistry       Date:  2017-10-10       Impact factor: 3.162

7.  Conformational biosensors reveal GPCR signalling from endosomes.

Authors:  Roshanak Irannejad; Jin C Tomshine; Jon R Tomshine; Michael Chevalier; Jacob P Mahoney; Jan Steyaert; Søren G F Rasmussen; Roger K Sunahara; Hana El-Samad; Bo Huang; Mark von Zastrow
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

Review 8.  Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

Authors:  Eric Reiter; Seungkirl Ahn; Arun K Shukla; Robert J Lefkowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-19       Impact factor: 13.820

9.  Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.

Authors:  Adrian J Butcher; Rudi Prihandoko; Kok Choi Kong; Phillip McWilliams; Jennifer M Edwards; Andrew Bottrill; Sharad Mistry; Andrew B Tobin
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

10.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  26 in total

1.  Detergent- and phospholipid-based reconstitution systems have differential effects on constitutive activity of G-protein-coupled receptors.

Authors:  Dean P Staus; Laura M Wingler; Dmitry Pichugin; Robert Scott Prosser; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor.

Authors:  Carl-Mikael Suomivuori; Naomi R Latorraca; Laura M Wingler; Stephan Eismann; Matthew C King; Alissa L W Kleinhenz; Meredith A Skiba; Dean P Staus; Andrew C Kruse; Robert J Lefkowitz; Ron O Dror
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

3.  Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.

Authors:  Laura M Wingler; Meredith A Skiba; Conor McMahon; Dean P Staus; Alissa L W Kleinhenz; Carl-Mikael Suomivuori; Naomi R Latorraca; Ron O Dror; Robert J Lefkowitz; Andrew C Kruse
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

Review 4.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

Review 5.  Incorporation of nonstandard amino acids into proteins: principles and applications.

Authors:  Tianwen Wang; Chen Liang; Hongjv Xu; Yafei An; Sha Xiao; Mengyuan Zheng; Lu Liu; Lei Nie
Journal:  World J Microbiol Biotechnol       Date:  2020-04-08       Impact factor: 3.312

6.  Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.

Authors:  Laura M Wingler; Matthias Elgeti; Daniel Hilger; Naomi R Latorraca; Michael T Lerch; Dean P Staus; Ron O Dror; Brian K Kobilka; Wayne L Hubbell; Robert J Lefkowitz
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

7.  Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Authors:  Laura M Wingler; Conor McMahon; Dean P Staus; Robert J Lefkowitz; Andrew C Kruse
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

8.  Synthetic nanobodies as angiotensin receptor blockers.

Authors:  Conor McMahon; Dean P Staus; Laura M Wingler; Jialu Wang; Meredith A Skiba; Matthias Elgeti; Wayne L Hubbell; Howard A Rockman; Andrew C Kruse; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-04       Impact factor: 11.205

Review 9.  Recent progress in enzymatic protein labelling techniques and their applications.

Authors:  Yi Zhang; Keun-Young Park; Kiall F Suazo; Mark D Distefano
Journal:  Chem Soc Rev       Date:  2018-09-27       Impact factor: 54.564

Review 10.  Postsynaptic localization and regulation of AMPA receptors and Cav1.2 by β2 adrenergic receptor/PKA and Ca2+/CaMKII signaling.

Authors:  Tommaso Patriarchi; Olivia R Buonarati; Johannes W Hell
Journal:  EMBO J       Date:  2018-09-24       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.